Inhaled Corticosteroids in COPD: Trying to Make a Long Story Short.


Journal

International journal of chronic obstructive pulmonary disease
ISSN: 1178-2005
Titre abrégé: Int J Chron Obstruct Pulmon Dis
Pays: New Zealand
ID NLM: 101273481

Informations de publication

Date de publication:
2020
Historique:
received: 04 10 2019
accepted: 21 02 2020
entrez: 6 5 2020
pubmed: 6 5 2020
medline: 29 6 2021
Statut: epublish

Résumé

The use of inhaled corticosteroids (ICSs) in long-term treatment of COPD has been a debated topic for a long time. According to the evidence produced till now, ICSs are presently advocated in combination with long-acting bronchodilators for high-risk symptomatic COPD patients with a history of frequent COPD exacerbations. However, the heterogeneity of COPD patients in terms of prevalent underlying disease, with its associated biological and functional characteristics, and different types of exacerbation makes this recommendation highly questionable. This review aims to discuss the usefulness of ICSs in the pharmacological management of COPD and trys to detect those aspects that may likely anticipate a beneficial response following their therapeutic use related to respiratory function, functional decline, prevention of exacerbation, and quality of life. In this respect, the BERN acronym, meaning Bronchiolitis, Eosinophilia, Responsiveness to bronchodilator, and Non-smoker, may be of practical utility to select among COPD patients those that can take more advantage from ICS adoption when positive and vice versa when negative.

Identifiants

pubmed: 32368028
doi: 10.2147/COPD.S233462
pii: 233462
pmc: PMC7182685
doi:

Substances chimiques

Adrenal Cortex Hormones 0
Bronchodilator Agents 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

821-829

Informations de copyright

© 2020 Tantucci and Pini.

Déclaration de conflit d'intérêts

The authors report no conflicts of interest in this work.

Références

PLoS One. 2014 Feb 05;9(2):e87443
pubmed: 24505290
Int J Chron Obstruct Pulmon Dis. 2015 Oct 15;10:2207-17
pubmed: 26527869
Am J Respir Crit Care Med. 2009 Nov 1;180(9):846-52
pubmed: 19661244
Am J Respir Crit Care Med. 2000 Nov;162(5):1773-7
pubmed: 11069811
Eur Respir J. 2016 May;47(5):1374-82
pubmed: 26917606
Eur Respir J. 2008 Jun;31(6):1274-84
pubmed: 18216057
Lancet Respir Med. 2018 Feb;6(2):117-126
pubmed: 29331313
N Engl J Med. 2010 Sep 16;363(12):1128-38
pubmed: 20843247
Thorax. 2012 Aug;67(8):701-8
pubmed: 22696176
Lancet Respir Med. 2016 May;4(5):390-8
pubmed: 27066739
Int J Chron Obstruct Pulmon Dis. 2012;7:587-95
pubmed: 23055709
Respir Med. 2008 Aug;102(8):1099-108
pubmed: 18614347
Am J Respir Crit Care Med. 2008 Jan 1;177(1):19-26
pubmed: 17916806
Lancet Respir Med. 2015 Jun;3(6):435-42
pubmed: 25878028
PLoS One. 2013 May 07;8(5):e63430
pubmed: 23667615
Am J Respir Crit Care Med. 2016 Jul 15;194(2):178-84
pubmed: 26808615
Am J Respir Crit Care Med. 2015 Apr 1;191(7):758-66
pubmed: 25611785
Am J Respir Crit Care Med. 2012 Jul 1;186(1):48-55
pubmed: 22447964
N Engl J Med. 2018 May 03;378(18):1671-1680
pubmed: 29668352
Eur J Pharmacol. 2001 Nov 23;431(3):365-71
pubmed: 11730731
N Engl J Med. 2000 Dec 28;343(26):1902-9
pubmed: 11136260
Ann Intern Med. 2009 Oct 20;151(8):517-27
pubmed: 19841453
Am J Respir Crit Care Med. 2013 May 1;187(9):933-42
pubmed: 23471465
Lancet Respir Med. 2018 Nov;6(11):855-862
pubmed: 30343028
JAMA. 2014 Sep 17;312(11):1114-21
pubmed: 25226477
Int J Chron Obstruct Pulmon Dis. 2016 Jul 01;11:1495-504
pubmed: 27445469
Am J Respir Crit Care Med. 2007 Jan 15;175(2):144-9
pubmed: 17053207
Thorax. 2013 Nov;68(11):1029-36
pubmed: 24130228
N Engl J Med. 2007 Feb 22;356(8):775-89
pubmed: 17314337
Lancet. 1999 May 29;353(9167):1819-23
pubmed: 10359405
J Appl Physiol (1985). 2000 Jun;88(6):1989-95
pubmed: 10846010
BMC Pulm Med. 2005 Feb 11;5:3
pubmed: 15707484
Cochrane Database Syst Rev. 2014 Mar 10;(3):CD010115
pubmed: 24615270
Int J Chron Obstruct Pulmon Dis. 2016 Feb 19;11 Spec Iss:21-30
pubmed: 26937187
Int J Chron Obstruct Pulmon Dis. 2015 Nov 11;10:2451-7
pubmed: 26648707
Eur Respir J. 2009 Sep;34(3):641-7
pubmed: 19443528
Lancet. 2003 Feb 8;361(9356):449-56
pubmed: 12583942
N Engl J Med. 2004 Jun 24;350(26):2645-53
pubmed: 15215480
Thorax. 2009 Aug;64(8):728-35
pubmed: 19638566
Thorax. 2005 Nov;60(11):925-31
pubmed: 16055622
Am J Respir Crit Care Med. 2011 Sep 15;184(6):662-71
pubmed: 21680942
Lancet. 2017 May 13;389(10082):1919-1929
pubmed: 28385353
Thorax. 2014 Jan;69(1):14-23
pubmed: 23925644
Radiology. 2015 Oct;277(1):192-205
pubmed: 25961632
Eur Respir J. 2006 May;27(5):964-71
pubmed: 16446316
Chest. 2017 Aug;152(2):227-231
pubmed: 28797382
Int J Chron Obstruct Pulmon Dis. 2016 Mar 11;11:515-25
pubmed: 27042040
Am J Respir Crit Care Med. 1999 Nov;160(5 Pt 1):1486-92
pubmed: 10556110
Eur Respir J. 2005 Mar;25(3):552-63
pubmed: 15738302
Eur Respir J. 2015 Feb;45(2):525-37
pubmed: 25537556
COPD. 2009 Oct;6(5):320-9
pubmed: 19863361
N Engl J Med. 1999 Jun 24;340(25):1948-53
pubmed: 10379018
Am J Respir Crit Care Med. 2012 Jan 1;185(1):44-52
pubmed: 22016444
Respir Med. 2003 Jun;97(6):591-8
pubmed: 12814141
Thorax. 2005 Mar;60(3):193-8
pubmed: 15741434
Chest. 2004 Aug;126(2):375-81
pubmed: 15302720
Am J Respir Crit Care Med. 2011 Sep 15;184(6):625-6
pubmed: 21920921
Lancet Respir Med. 2018 Oct;6(10):747-758
pubmed: 30232048
Am J Respir Crit Care Med. 2015 Aug 15;192(4):523-5
pubmed: 26051430
Lancet Respir Med. 2015 Jun;3(6):416-7
pubmed: 25892351
Int J Chron Obstruct Pulmon Dis. 2017 Mar 27;12:1009-1018
pubmed: 28392685
Lancet. 2018 Mar 17;391(10125):1076-1084
pubmed: 29429593
Int J Chron Obstruct Pulmon Dis. 2012;7:283-9
pubmed: 22589579
Am J Respir Crit Care Med. 1998 Nov;158(5 Pt 1):1511-7
pubmed: 9817701
PLoS One. 2015 Dec 10;10(12):e0143793
pubmed: 26659582
Eur Respir J. 2017 Mar 15;49(3):
pubmed: 28298398
Pulm Pharmacol Ther. 2011 Feb;24(1):15-22
pubmed: 20816832

Auteurs

Claudio Tantucci (C)

Department of Clinical and Experimental Sciences, Respiratory Medicine Unit, University of Brescia, Brescia, Italy.

Laura Pini (L)

Department of Clinical and Experimental Sciences, Respiratory Medicine Unit, University of Brescia, Brescia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH